Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Open Forum Infectious Diseases|March 4, 2015
Seroincidence of Influenza Among HIV-infected and HIV-uninfected Men During the 2009 H1N1 Influenza Pandemic, Bangkok, ThailandShikha Garg, Sonja J Olsen, Stefan Fernandez, et al.AIDS (London, England)|December 15, 2010
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control studyMarcel E Curlin, Farah Cassis-Ghavami, Amalia S Magaret, et al.WHO South-East Asia Journal of Public Health|April 6, 2019
Hepatitis C virus infection among people who inject drugs in Bangkok, Thailand, 2005-2010Michael Martin, Suphak Vanichseni, Wanna Leelawiwat, et al.Cell Reports|October 17, 2022
BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.Medrxiv : the Preprint Server for Health Sciences|August 29, 2022
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with ageTimothy A Bates, Pei Lu, Ye Jin Kang, et al.Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Previously infected vaccinees broadly neutralize SARS-CoV-2 variantsHans C Leier, Timothy A Bates, Zoe L Lyski, et al.Science Immunology|January 25, 2022
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variantsTimothy A Bates, Savannah K McBride, Hans C Leier, et al.American Journal of Public Health|April 17, 2015
High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012Suphak Vanichseni, Michael Martin, Pravan Suntharasamai, et al.Plos One|March 27, 2014
Risk behaviors and risk factors for HIV infection among participants in the Bangkok tenofovir study, an HIV pre-exposure prophylaxis trial among people who inject drugsMichael Martin, Suphak Vanichseni, Pravan Suntharasamai, et al.Influenza and Other Respiratory Viruses|June 10, 2026
Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity StudyLena Pracher, Mastura Wahedi, Anselm Jorda, et al.Pageof 7